Sharon Lim
Australia-listed Symbion Health has received an unsolicited takeover proposal from a consortium of two buyout firms and a strategic rival keen to acquire Symbion’s pathology, medical centres and diagnostic imaging businesses.
Top US venture firm Kleiner Perkins Caufield & Byers has entered China with a $360 million fund and a seasoned team of local investment professionals.
Top US venture firm Kleiner Perkins Caufield & Byers has entered China with a $360 million fund and a seasoned team of local investment professionals.
The Carlyle Group has sold its stake in a Japanese automobile parts maker for $106 million to Tokyo-listed THK, manufacturer of liner motion systems.
The Carlyle Group has sold its stake in a Japanese automobile parts maker for $106 million to Tokyo-listed THK, manufacturer of liner motion systems.
The Carlyle Group has made the first Japanese investment from its pan-Asian growth capital fund, backing a semiconductor assembly and testing services provider.
The Carlyle Group has made the first Japanese investment from its pan-Asian growth capital fund, backing a semiconductor assembly and testing services provider.
Archer Capital has agreed to buy five wine-related businesses across Australia, New Zealand and Japan from Melbourne-based Foster’s Group for an estimated A$200 million.
Archer Capital has agreed to buy five wine-related businesses across Australia, New Zealand and Japan from Melbourne-based Foster’s Group for an estimated A$200 million.
CITIC Capital Partners has raised $425 million for its first China-focused private equity fund, smashing its $350 million hard cap. Investors are banking on CITIC to access control deals in Chinese state-owned enterprises.